Search Login Register

Gangliosidoses (Gangliosidosis) Summary

Description: A group of autosomal recessive lysosomal storage disorders marked by the accumulation of GANGLIOSIDES. They are caused by impaired enzymes or defective cofactors required for normal ganglioside degradation in the LYSOSOMES. Gangliosidoses are classified by the specific ganglioside accumulated in the defective degradation pathway.

Also Known As: Gangliosidosis; Ganglioside Storage Diseases; Ganglioside Storage Disorders; Ganglioside Storage Disease; Ganglioside Storage Disorder Show All >>

Networked: 86 relevant articles (1 outcomes, 7 trials/studies) for this Disease

Key Drugs and Agents for Gangliosidoses

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. beta-Galactosidase (Lactaid) : 1 outcome in 9 results : IBA
  2. Gangliosides : 1 study in 10 results : IBA
  3. Hexosaminidases (Hexosaminidase) : 1 study in 9 results : IBA
  4. Neutral Glycosphingolipids : 1 study in 1 result : IBA
  5. Fluorescein (Funduscein) : 1 study in 1 result : FDA 3 Generic
  6. Protein Kinase C : 1 study in 1 result : IBA
  7. Galactose (Galactopyranose) : 1 study in 1 result : FDA 3 Generic
  8. Carisoprodol (Soma) : 1 study in 1 result : FDA 29 Generic
  9. Amino Acids : 1 study in 1 result : FDA 53
  10. 1-deoxygalactonojirimycin : 1 study in 1 result : IBA
Show All >>

Diseases Related to Gangliosidoses

  1. Mucopolysaccharidoses
  2. Tay-Sachs Disease
  3. GM1 Gangliosidosis (Gangliosidosis GM1)
  4. Mucopolysaccharidosis IV (Morquio Syndrome)
  5. Fabry Disease (Fabry's Disease)
Show All >>

Key Therapies for Gangliosidoses

Efficacy Chart >>
  1. Deep Brain Stimulation : 1 result
  2. Transplantation (Transplant Recipients) : 1 result
  3. Euthanasia (Mercy Killing) : 1 result

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.